INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • Wednesday
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingBusiness Wire • Tuesday
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingBusiness Wire • 04/22/24
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/19/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBPRNewsWire • 04/04/24
ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/04/24
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/03/24
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/29/24
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 03/27/24
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/22/24
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 03/21/24
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. Incorporated and Encourages Investors with Losses to Contact the FirmAccesswire • 03/14/24
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesBusiness Wire • 03/13/24
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHBusiness Wire • 03/13/24
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceBusiness Wire • 01/30/24
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaBusiness Wire • 01/22/24
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHBusiness Wire • 01/05/24
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesBusiness Wire • 11/13/23
Spruce Biosciences to Participate in the Jefferies London Healthcare ConferenceBusiness Wire • 11/02/23
Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)Benzinga • 10/20/23
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal HyperplasiaBusiness Wire • 10/18/23